IPO Monitor: Latest IPO News (beta)

[ All Markets | U.S. | Canada | Europe | China ]

BRIEF-Principia Biopharma Inc Files For IPO Of Up To $86.3 Million

Principia Biopharma Inc. * PRINCIPIA BIOPHARMA INC FILES FOR IPO OF UP TO $86.3 MILLION Â SEC FILING. * PRINCIPIA BIOPHARMA INC SAYS IT INTENDS TO APPLY TO HAVE ITS COMMON STOCK LISTED ON NASDAQ GLOBAL MARKET UNDER THE SYMBOL "PRNB" * PRINCIPIA BIOPHARMA INC SAYS BOFA MERRILL LYNCH, LEERINK PARTNERS, WELLS FARGO SECURITIES ARE AMONG UNDERWRITERS TO IPO.
[ Fidelity at 2018-08-17 14:35:56 ]

BRIEF-Entasis Therapeutics Files For IPO Of Up To $86.3 Million

Entasis Therapeutics Holdings Inc. * ENTASIS THERAPEUTICS HOLDINGS INC FILES FOR IPO OF UP TO $86.3 MILLION Â SEC FILING. * ENTASIS THERAPEUTICS HOLDINGS INC SAYS IT INTENDS TO APPLY TO HAVE ITS COMMON STOCK LISTED ON NASDAQ GLOBAL MARKET UNDER THE SYMBOL "ETTX" * ENTASIS THERAPEUTICS HOLDINGS INC SAYS CREDIT SUISSE, BMO CAPITAL MARKETS, SUNTRUST ROBINSON HUMPHREY ARE AMONG UNDERWRITERS TO IPO.
[ Fidelity at 2018-08-17 14:24:58 ]

SEC vs. Tilray: What regulators wanted to know about the largest U.S. pot IPO

Tilray(TLRY) removed entire CEO letter from IPO filing, according to SEC documents. As the largest pot IPO in the U.S. was on deck earlier this year, the Securities and Exchange Commission sought to cut down on Tilray Inc.' s soaring rhetoric and add disclosures about the side effects of weed, according to SEC documents made public this week. Among other changes, the SEC's comments led the company to pull a letter to shareholders from Chief Executive Brendan Kennedy.
[ Fidelity at 2018-08-17 03:56:03 ]

SEC vs. Tilray: What regulators wanted to know about the largest U.S. pot IPO

BRIEF-Cootek (Cayman)Â Inc Files For U.S. IPO Of Up To $100 Mln

Cootek INC: * COOTEK INC FILES FOR U.S. IPO OF UP TO $100 MILLION Â SEC FILING. * COOTEK INC SAYS IT INTENDS TO APPLY TO HAVE ITS ADS LISTED ON NEW YORK STOCK EXCHANGE UNDER THE SYMBOL "CTK" * COOTEK INC SAYS CREDIT SUISSE, BOFA MERRILL LYNCH, CITIGROUP ARE AMONG UNDERWRITERS TO IPO. * COOTEK INC SAYS PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR CALCULATING SEC REGISTRATION FEE Source text:
[ Fidelity at 2018-08-16 09:23:27 ]

TKK Symphony Acquisition Prices IPO of 22 Mln Units at $10 Each; Trading on Nasdaq to Begin Thursday

TKK Symphony Acquisition Corp.(TKKSU), a company formed for the purpose of entering into a merger, share exchange, and asset acquisition, said early Thursday that it priced its initial public offering of 22 million units at $10.00 each on Aug. 15. The units are expected to be listed on the Nasdaq Capital Market and trade under ticker symbol "TKKSU" beginning Thursday, according to a statement.
[ Fidelity at 2018-08-16 05:37:13 ]

BRIEF-TKK Symphony Acquisition Prices Offering Of 22 Mln Shares Priced At $10 Per Share

TKK Symphony Acquisition Corporation(TKKSU) : * ORATION ANNOUNCES PRICING OF $220 MILLION INITIAL PUBLIC OFFERING. * SAYS INITIAL PUBLIC OFFERING OF 22.0 MILLION SHARES PRICED AT $10.00PER SHARE Source text for Eikon: Further company coverage:
[ Fidelity at 2018-08-16 05:17:28 ]

BRIEF-YayYo Inc Sees IPO Of 625,000 Shares Priced Between $7.00 - $9.00 Per Share â SEC Filing

YayYo Inc: * YAYYO INC SEES IPO OF 625,000 SHARES PRICED TO BE BETWEEN $7.00 AND $9.00 PER SHARE Â SEC FILING. * YAYYO INC SAYS IT HAD PREVIOUSLY EXPECTED IPO OF UP TO 1.25 MILLION SHARES OF COMMON STOCK PRICED BETWEEN BETWEEN $7.00 AND $9.00 PER SHARE Source text: [https://bit.ly/2KXk8OA] Further company coverage:
[ Fidelity at 2018-08-16 03:25:47 ]

Alibaba-backed online parenting firm Babytree eyeing up to $1 bln HK IPO -sources

* Babytree looking to raise $800 mln to $1 bln in HK IPO -sources. * Babytree targeting valuation of $3 bln-$5 bln -sources. * Plans to seek nod from listing committee in late Sept -sources. By Julie Zhu and Fiona Lau.
[ Fidelity at 2018-08-16 00:59:36 ]

Magna Gold Corp. Announces Closing of Initial Public Offering

[ GlobeNewswire at 2018-08-15 13:55:00 ]

BRIEF-111 Inc Files For U.S. IPO Of Up To $200 Million

111 Inc : * 111 INC FILES FOR U.S. IPO OF UP TO $200 MILLION Â SEC FILING. * 111 INC SAYS IT INTENDS TO APPLY TO HAVE ITS ADS LISTED ON NEW YORK STOCK EXCHANGE/NASDAQ GLOBAL MARKET UNDER THE SYMBOL "YI" * 111 INC SAYS J.P. MORGAN, CITIGROUP, CICC ARE AMONG UNDERWRITERS TO IPO. * 111 INC SAYS PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR CALCULATING SEC REGISTRATION FEE Source text :
[ Fidelity at 2018-08-15 11:58:59 ]

BioNano Genomics to offer 2.45 million shares in IPO priced at $6 to $7 each

BioNano Genomics Inc. set terms for its initial public offering on Wednesday, saying in a regulatory filing that it will offer 2.45 million shares priced at $6 to $7 each. The biotech would raise about $16 million at the midpoint of the range. The company is planning to list on Nasdaq under the ticker symbol "BNGO."
[ Fidelity at 2018-08-15 04:17:29 ]

BRIEF-Bionano Genomics Inc Sees IPO Of 2.45 mln Units Priced To Be Between $6 And $7 Per Unit

* BIONANO GENOMICS, INC. SEES IPO OF 2.45 MILLION UNITS PRICED TO BE BETWEEN $6 AND $7 PER UNITÂ SEC FILING. * BIONANO GENOMICS INC SAYS IT HAD PREVIOUSLY EXPECTED IPO OF UP TO 5.5 MLN SHARES OF COMMON STOCK PRICED BETWEEN BETWEEN $5 AND $6 PER SHARE.
[ Fidelity at 2018-08-15 03:52:09 ]

Aridis' shares rise in muted market debut

Biotechnology company Aridis Pharmaceuticals Inc (ARDS) rose as much as 5.4 percent to $13.70 in its U.S. market debut on Tuesday, joining a host of other small-cap biotechs that have gone public this year. Shares opened at $13.02, above the initial public offering price of $13 per share.
[ Fidelity at 2018-08-14 07:28:14 ]

Sector Update: Health Care

Shares in health care companies were steady ahead of the bell on Tuesday, with Pfizer flat, Johnson & Johnson flat, Abbott Laboratories flat, Amgen flat and Merck also unchanged. In health care stock news, Aridis Pharmaceuticals (ARDS) said late Monday that it has priced an initial public offering of 2 million common shares at $13 apiece, for gross proceeds of $26 million.
[ Fidelity at 2018-08-14 05:36:46 ]

Aridis Pharmaceuticals Prices IPO of 2 Mln Shares at $13 Per Share

Aridis Pharmaceuticals(ARDS) said late Monday that it has priced an initial public offering of 2 million common shares at $13 apiece, for gross proceeds of $26 million. Underwriters were granted a 30-day option to buy up to an additional 300,000 shares. The shares are expected to begin trading on the Nasdaq Capital Market on Aug. 14 under the ticker "ARDS."
[ Fidelity at 2018-08-14 02:20:02 ]

BRIEF-Aridis pharma says IPO Of 2 Mln Shares Priced At $13/ Shr

Aridis Pharmaceuticals Inc(ARDS): * ARIDIS PHARMACEUTICALS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING. * SAYS INITIAL PUBLIC OFFERING OF 2.00 MILLION COMMON SHARES PRICED AT $13.00PER SHARE Source text for Eikon: Further company coverage:
[ Fidelity at 2018-08-13 16:33:44 ]

BRIEF-MDJM Ltd Files For U.S. IPO Of Up To $8 Mln

MDJM Ltd: * MDJM LTD FILES FOR U.S. IPO OF UP TO $8.0 MILLION - SEC FILING. * MDJM LTD SAYS IN THE PROCESS OF APPLYING TO LIST ORDINARY SHARES ON NASDAQ CAPITAL MARKET UNDER THE SYMBOL ÂMDJHÂ. * MDJM LTD - PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR CALCULATING SEC REGISTRATION FEE Source:
[ Fidelity at 2018-08-13 15:31:42 ]

BRIEF-NIO Inc Files For U.S. IPO Of Up To $1.8 Bln

NIO Inc: * NIO INC FILES FOR U.S. IPO OF UP TO $1,800 MILLION Â SEC FILING. * NIO INC SAYS IT INTENDS TO APPLY TO HAVE ITS ADS LISTED ON NEW YORK STOCK EXCHANGE UNDER THE SYMBOL "NIO" * NIO INC SAYS MORGAN STANLEY, GOLDMAN SACHS L.L.C, J.P. MORGAN ARE AMONG UNDERWRITERS TO IPO. * NIO INC SAYS CITIGROUP, CREDIT SUISSE ARE AMONG UNDERWRITERS TO IPO.
[ Fidelity at 2018-08-13 14:17:35 ]

BRIEF-Remora Royalties Inc Adds Stifel, Stephens Inc And Seaport Global Securities To Its List Of Underwriters To IPO

Remora Royalties Inc: * REMORA ROYALTIES INC ADDS STIFEL, STEPHENS INC AND SEAPORT GLOBAL SECURITIES TO ITS LIST OF UNDERWRITERS TO IPO - SEC FILING Source text - Further company coverage:
[ Fidelity at 2018-08-13 10:21:22 ]

More IPO News >>



Initial Public Offerings IPO News (beta) Recent Filings IPO Calendar Recent Pricings IPO Withdrawals Quiet Period Deal Flow Lockup Expirations Best-Worst Performers Industry Analysis Underwriter Performance Quarterly Reviews Secondary Offerings Recent Filings Calendar Recent Pricings Quiet Period Deal Flow Best-Worst Performers Industry Analysis Underwriter Performance Quarterly Reviews Tools Search Recent Events Underwriters Aftermarket Report	Latest IPO News (beta) [ All Markets \| U.S. \| Canada \| Europe \| China ] BRIEF-Principia Biopharma Inc Files For IPO Of Up To $86.3 Million Principia Biopharma Inc. * PRINCIPIA BIOPHARMA INC FILES FOR IPO OF UP TO $86.3 MILLION Â SEC FILING. * PRINCIPIA BIOPHARMA INC SAYS IT INTENDS TO APPLY TO HAVE ITS COMMON STOCK LISTED ON NASDAQ GLOBAL MARKET UNDER THE SYMBOL "PRNB" * PRINCIPIA BIOPHARMA INC SAYS BOFA MERRILL LYNCH, LEERINK PARTNERS, WELLS FARGO SECURITIES ARE AMONG UNDERWRITERS TO IPO. [ Fidelity at 2018-08-17 14:35:56 ] BRIEF-Entasis Therapeutics Files For IPO Of Up To $86.3 Million Entasis Therapeutics Holdings Inc. * ENTASIS THERAPEUTICS HOLDINGS INC FILES FOR IPO OF UP TO $86.3 MILLION Â SEC FILING. * ENTASIS THERAPEUTICS HOLDINGS INC SAYS IT INTENDS TO APPLY TO HAVE ITS COMMON STOCK LISTED ON NASDAQ GLOBAL MARKET UNDER THE SYMBOL "ETTX" * ENTASIS THERAPEUTICS HOLDINGS INC SAYS CREDIT SUISSE, BMO CAPITAL MARKETS, SUNTRUST ROBINSON HUMPHREY ARE AMONG UNDERWRITERS TO IPO. [ Fidelity at 2018-08-17 14:24:58 ] SEC vs. Tilray: What regulators wanted to know about the largest U.S. pot IPO Tilray(TLRY) removed entire CEO letter from IPO filing, according to SEC documents. As the largest pot IPO in the U.S. was on deck earlier this year, the Securities and Exchange Commission sought to cut down on Tilray Inc.' s soaring rhetoric and add disclosures about the side effects of weed, according to SEC documents made public this week. Among other changes, the SEC's comments led the company to pull a letter to shareholders from Chief Executive Brendan Kennedy. [ Fidelity at 2018-08-17 03:56:03 ] SEC vs. Tilray: What regulators wanted to know about the largest U.S. pot IPO Tilray(TLRY) removed entire CEO letter from IPO filing, according to SEC documents. As the largest pot IPO in the U.S. was on deck earlier this year, the Securities and Exchange Commission sought to cut down on Tilray Inc.' s soaring rhetoric and add disclosures about the side effects of weed, according to SEC documents made public this week. Among other changes, the SEC's comments led the company to pull a letter to shareholders from Chief Executive Brendan Kennedy. [ Fidelity at 2018-08-16 17:53:26 ] BRIEF-Cootek (Cayman)Â Inc Files For U.S. IPO Of Up To $100 Mln Cootek INC: * COOTEK INC FILES FOR U.S. IPO OF UP TO $100 MILLION Â SEC FILING. * COOTEK INC SAYS IT INTENDS TO APPLY TO HAVE ITS ADS LISTED ON NEW YORK STOCK EXCHANGE UNDER THE SYMBOL "CTK" * COOTEK INC SAYS CREDIT SUISSE, BOFA MERRILL LYNCH, CITIGROUP ARE AMONG UNDERWRITERS TO IPO. * COOTEK INC SAYS PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR CALCULATING SEC REGISTRATION FEE Source text: [ Fidelity at 2018-08-16 09:23:27 ] TKK Symphony Acquisition Prices IPO of 22 Mln Units at $10 Each; Trading on Nasdaq to Begin Thursday TKK Symphony Acquisition Corp.(TKKSU), a company formed for the purpose of entering into a merger, share exchange, and asset acquisition, said early Thursday that it priced its initial public offering of 22 million units at $10.00 each on Aug. 15. The units are expected to be listed on the Nasdaq Capital Market and trade under ticker symbol "TKKSU" beginning Thursday, according to a statement. [ Fidelity at 2018-08-16 05:37:13 ] BRIEF-TKK Symphony Acquisition Prices Offering Of 22 Mln Shares Priced At $10 Per Share TKK Symphony Acquisition Corporation(TKKSU) : * ORATION ANNOUNCES PRICING OF $220 MILLION INITIAL PUBLIC OFFERING. * SAYS INITIAL PUBLIC OFFERING OF 22.0 MILLION SHARES PRICED AT $10.00PER SHARE Source text for Eikon: Further company coverage: [ Fidelity at 2018-08-16 05:17:28 ] BRIEF-YayYo Inc Sees IPO Of 625,000 Shares Priced Between $7.00 - $9.00 Per Share â SEC Filing YayYo Inc: * YAYYO INC SEES IPO OF 625,000 SHARES PRICED TO BE BETWEEN $7.00 AND $9.00 PER SHARE Â SEC FILING. * YAYYO INC SAYS IT HAD PREVIOUSLY EXPECTED IPO OF UP TO 1.25 MILLION SHARES OF COMMON STOCK PRICED BETWEEN BETWEEN $7.00 AND $9.00 PER SHARE Source text: [https://bit.ly/2KXk8OA] Further company coverage: [ Fidelity at 2018-08-16 03:25:47 ] Alibaba-backed online parenting firm Babytree eyeing up to $1 bln HK IPO -sources * Babytree looking to raise $800 mln to $1 bln in HK IPO -sources. * Babytree targeting valuation of $3 bln-$5 bln -sources. * Plans to seek nod from listing committee in late Sept -sources. By Julie Zhu and Fiona Lau. [ Fidelity at 2018-08-16 00:59:36 ] Magna Gold Corp. Announces Closing of Initial Public Offering [ GlobeNewswire at 2018-08-15 13:55:00 ] BRIEF-111 Inc Files For U.S. IPO Of Up To $200 Million 111 Inc : * 111 INC FILES FOR U.S. IPO OF UP TO $200 MILLION Â SEC FILING. * 111 INC SAYS IT INTENDS TO APPLY TO HAVE ITS ADS LISTED ON NEW YORK STOCK EXCHANGE/NASDAQ GLOBAL MARKET UNDER THE SYMBOL "YI" * 111 INC SAYS J.P. MORGAN, CITIGROUP, CICC ARE AMONG UNDERWRITERS TO IPO. * 111 INC SAYS PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR CALCULATING SEC REGISTRATION FEE Source text : [ Fidelity at 2018-08-15 11:58:59 ] BioNano Genomics to offer 2.45 million shares in IPO priced at $6 to $7 each BioNano Genomics Inc. set terms for its initial public offering on Wednesday, saying in a regulatory filing that it will offer 2.45 million shares priced at $6 to $7 each. The biotech would raise about $16 million at the midpoint of the range. The company is planning to list on Nasdaq under the ticker symbol "BNGO." [ Fidelity at 2018-08-15 04:17:29 ] BRIEF-Bionano Genomics Inc Sees IPO Of 2.45 mln Units Priced To Be Between $6 And $7 Per Unit * BIONANO GENOMICS, INC. SEES IPO OF 2.45 MILLION UNITS PRICED TO BE BETWEEN $6 AND $7 PER UNITÂ SEC FILING. * BIONANO GENOMICS INC SAYS IT HAD PREVIOUSLY EXPECTED IPO OF UP TO 5.5 MLN SHARES OF COMMON STOCK PRICED BETWEEN BETWEEN $5 AND $6 PER SHARE. [ Fidelity at 2018-08-15 03:52:09 ] Aridis' shares rise in muted market debut Biotechnology company Aridis Pharmaceuticals Inc (ARDS) rose as much as 5.4 percent to $13.70 in its U.S. market debut on Tuesday, joining a host of other small-cap biotechs that have gone public this year. Shares opened at $13.02, above the initial public offering price of $13 per share. [ Fidelity at 2018-08-14 07:28:14 ] Sector Update: Health Care Shares in health care companies were steady ahead of the bell on Tuesday, with Pfizer flat, Johnson & Johnson flat, Abbott Laboratories flat, Amgen flat and Merck also unchanged. In health care stock news, Aridis Pharmaceuticals (ARDS) said late Monday that it has priced an initial public offering of 2 million common shares at $13 apiece, for gross proceeds of $26 million. [ Fidelity at 2018-08-14 05:36:46 ] Aridis Pharmaceuticals Prices IPO of 2 Mln Shares at $13 Per Share Aridis Pharmaceuticals(ARDS) said late Monday that it has priced an initial public offering of 2 million common shares at $13 apiece, for gross proceeds of $26 million. Underwriters were granted a 30-day option to buy up to an additional 300,000 shares. The shares are expected to begin trading on the Nasdaq Capital Market on Aug. 14 under the ticker "ARDS." [ Fidelity at 2018-08-14 02:20:02 ] BRIEF-Aridis pharma says IPO Of 2 Mln Shares Priced At $13/ Shr Aridis Pharmaceuticals Inc(ARDS): * ARIDIS PHARMACEUTICALS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING. * SAYS INITIAL PUBLIC OFFERING OF 2.00 MILLION COMMON SHARES PRICED AT $13.00PER SHARE Source text for Eikon: Further company coverage: [ Fidelity at 2018-08-13 16:33:44 ] BRIEF-MDJM Ltd Files For U.S. IPO Of Up To $8 Mln MDJM Ltd: * MDJM LTD FILES FOR U.S. IPO OF UP TO $8.0 MILLION - SEC FILING. * MDJM LTD SAYS IN THE PROCESS OF APPLYING TO LIST ORDINARY SHARES ON NASDAQ CAPITAL MARKET UNDER THE SYMBOL ÂMDJHÂ. * MDJM LTD - PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR CALCULATING SEC REGISTRATION FEE Source: [ Fidelity at 2018-08-13 15:31:42 ] BRIEF-NIO Inc Files For U.S. IPO Of Up To $1.8 Bln NIO Inc: * NIO INC FILES FOR U.S. IPO OF UP TO $1,800 MILLION Â SEC FILING. * NIO INC SAYS IT INTENDS TO APPLY TO HAVE ITS ADS LISTED ON NEW YORK STOCK EXCHANGE UNDER THE SYMBOL "NIO" * NIO INC SAYS MORGAN STANLEY, GOLDMAN SACHS L.L.C, J.P. MORGAN ARE AMONG UNDERWRITERS TO IPO. * NIO INC SAYS CITIGROUP, CREDIT SUISSE ARE AMONG UNDERWRITERS TO IPO. [ Fidelity at 2018-08-13 14:17:35 ] BRIEF-Remora Royalties Inc Adds Stifel, Stephens Inc And Seaport Global Securities To Its List Of Underwriters To IPO Remora Royalties Inc: * REMORA ROYALTIES INC ADDS STIFEL, STEPHENS INC AND SEAPORT GLOBAL SECURITIES TO ITS LIST OF UNDERWRITERS TO IPO - SEC FILING Source text - Further company coverage: [ Fidelity at 2018-08-13 10:21:22 ] More IPO News >>